Aedan J. Rourke

Aedan J. Rourke

Auto-generated profile, based on publicly available information

Aedan J. Rourke

Department of Kinesiology McMaster University Hamilton ON Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2025 in The Journal of Physiology
Verified
Journal Article
Open access
ARAedan J. Rourke
Aedan J. Rourke
CYClaudia M.S. Yong
Claudia M.S. Yong
GCGeoff B. Coombs
Geoff B. Coombs
AOAddriana R. Odisho
Addriana R. Odisho
JNJenna A. Nash
Jenna A. Nash
JWJeremy J. Walsh
Jeremy J. Walsh
Exogenous ketone monoester (KME) supplements rapidly increase plasma beta‐hydroxybutyrate (β‐OHB) and may impact cerebral blood flow (CBF). However, it is currently unknown how acute KME ingestion impacts resting CBF and whether differences in KME dose have differential effects on CBF regulation. The purpose of this study was to investigate the effect of two separate KME doses on resting CBF in young adults. On separate days and in a double‐blind, placebo‐controlled, cross‐over design, 20 participants (10 females; aged 23 ± 3 years) ingested either: (1) High‐KME (0.6 g kg −1 β‐OHB); (2) Low‐KME (0.3 g kg −1 β‐OHB); or (3) placebo drink, and quietly rested for 120 min. Global CBF (gCBF) was assessed using duplex ultrasound of the internal carotid and vertebral arteries, and transcranial Doppler ultrasound was used to assess middle cerebral artery blood velocity at baseline, 45 min and 120 min post‐ingestion. End‐tidal CO 2 () was measured using a gas analyser. β‐OHB was measured in venous blood. At 45 min post‐ingestion, gCBF was significantly reduced by 10.6% in Low‐KME and by 14.6% in High‐KME compared to baseline. At 120 min, gCBF returned towards baseline in Low‐KME, whereas gCBF was further reduced by 19.1% in High‐KME compared to baseline. KME dose‐dependent reductions in may have contributed to these reductions in gCBF following KME ingestion. These novel findings provide a foundational characterization of the impact of KME on resting CBF, which prompts further investigation building on these results to isolate underlying mechanisms and develop dosing protocols to mitigate potential CO 2 disruptions. image Key points: Beta‐hydroxybutyrate (β‐OHB) is a signalling molecule and β‐OHB infusion increases cerebral blood flow (CBF) in humans. Ingestion of higher doses of a ketone monoester (KME) supplement have been shown to lower blood pH and arterial CO 2 , which are important regulators of CBF. This double‐blind and placebo‐controlled cross‐over study tested the effects of two separate KME doses (Low‐KME and High‐KME) on resting CBF, end‐tidal CO 2 and systemic haemodynamics over a 2 h period post‐ingestion in young adults. Low‐KME reduced CBF 45 min post‐ingestion and High‐KME reduced CBF at both 45 and 120 min post‐ingestion, which corresponded with dose‐dependent reductions in end‐tidal CO 2 . The findings from this trial represent a foundational characterization of the effects of KME dose on resting CBF.

23 November 2024 in The Journal of Physiology
Verified
Journal Article
Closed access
SMStuart P. S. Mladen
Stuart P. S. Mladen
JBJack Bone
Jack Bone
JRJohn R. M. Renwick
John R. M. Renwick
ARAedan J. Rourke
Aedan J. Rourke

10 August 2025 in The Journal of Physiology
Verified
Journal Article
Closed access
ARAedan J. Rourke
Aedan J. Rourke
CYClaudia M. S. Yong
Claudia M. S. Yong
GCGeoff B. Coombs
Geoff B. Coombs
AOAddriana R. Odisho
Addriana R. Odisho
JNJenna A. Nash
Jenna A. Nash
JWJeremy J. Walsh
Jeremy J. Walsh

19 November 2026 in Journal of Applied Physiology
Verified
Journal Article
Closed access
CYClaudia M.S. Yong
Claudia M.S. Yong
ARAedan J. Rourke
Aedan J. Rourke
GCGeoff B. Coombs
Geoff B. Coombs
AOAddriana R. Odisho
Addriana R. Odisho
JNJenna A. Nash
Jenna A. Nash
JWJeremy J. Walsh
Jeremy J. Walsh
Ketone monoester (KME) ingestion lowers cerebral blood flow (CBF), likely due to reduced arterial carbon dioxide (P a CO 2 ). We tested the hypothesis that maintaining end-tidal CO 2 (P ET CO 2 ; surrogate for P a CO 2 ) following KME ingestion would prevent reductions in CBF and improve cerebrovascular reactivity (CVR) to CO 2 compared to free-breathing. In a single-blinded randomized crossover design, twenty-three adults (age=22±2 yrs) ingested 0.6 g·kg -1 KME and breathed either room air (poikilocapnia) or a gas mixture that clamped P ET CO 2 at baseline (isocapnia) for 60 min. CVR to CO 2 was assessed at targeted P ET CO 2 of +3, +6, and +9 mmHg above baseline. CBF was assessed using duplex ultrasound of extracranial arteries and transcranial Doppler ultrasound of the middle cerebral artery. Venous β-hydroxybutyrate, pH, and bicarbonate were measured. Outcomes were assessed at baseline, 45-, and 60-min post-supplementation. P ET CO 2 was higher during isocapnia at 45 min (3.9±3.8 mmHg; P<0.001) and 60 min (4.4±3.8 mmHg; P<0.001) post-supplementation corresponding with 15% higher CBF compared to poikilocapnia ( P<0.001). Blood pH was reduced during isocapnia ( P<0.001), whereas it was unchanged in poikilocapnia ( P=0.246), suggesting that the ventilatory response to KME ingestion effectively buffered metabolic acidosis in poikilocapnia. CVR to CO 2 was reduced following KME ingestion regardless of condition ( P<0.001). Exploratory analyses demonstrated that biological sex did not alter cerebrovascular responses to KME ingestion. This work confirms that reductions in CBF and CVR to CO 2 following KME ingestion are due to reduced P a CO 2 in response to metabolic acidosis. Strategies that buffer metabolic acidosis likely will mitigate CBF reductions following acute KME ingestion.